AbbVie director granted 35 stock equivalent units

Alpern Robert J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Alpern Robert J reported acquisition or exercise transactions in this Form 4 filing.

AbbVie Inc. director Robert J. Alpern received a grant of 35 stock equivalent units tied to AbbVie common stock as director compensation. The units were credited on the basis of director fees at a reference value of $217.49 per unit and track the return of AbbVie shares.

Following this award, Alpern’s balance increased to 10,369 stock equivalent units held in grantor trust accounts. These units are payable in cash, generally at age 65 or when he retires from the AbbVie board, and the balance also reflects units added through a dividend reinvestment feature.

Insider Trade Summary

Grant/Award: 35 shares

Grant/Award 1 txn

Insider Alpern Robert J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Equivalent Units	35	$217.49	$8K

Holdings After Transaction: Stock Equivalent Units — 10,369 contracts (Direct)

Footnotes (2)

1. F1. Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.
2. F2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Key Figures

Stock equivalent units granted: 35 units Reference price per unit: $217.49 per unit Total stock equivalent units after grant: 10,369 units

3 metrics

Stock equivalent units granted 35 units Director fee grant on 2026-03-31

Reference price per unit $217.49 per unit Value used for the 35-unit grant

Total stock equivalent units after grant 10,369 units Balance following the 35-unit award

Key Terms

Stock Equivalent Units, grantor trusts, dividend reinvestment feature

3 terms

Stock Equivalent Units financial

"Director fees credited to stock equivalent unit accounts under grantor trusts"

Stock equivalent units are financial claims or instruments that are treated as if they were actual shares for purposes like calculating ownership, dilution, and earnings per share. Think of them as promises or placeholders for future slices of company pie—options, restricted units, or convertible securities—that don’t yet sit on the table but will reduce each existing slice when converted. Investors track them because they change how much of a company each share really represents and can affect valuation and voting power.

grantor trusts financial

"stock equivalent unit accounts under grantor trusts established by the director"

dividend reinvestment feature financial

"Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature"

FAQ

What did AbbVie (ABBV) director Robert Alpern report in this Form 4?

Robert J. Alpern reported receiving 35 stock equivalent units as director compensation. These units are tied to AbbVie’s common stock value and increase his total balance to 10,369 units, all payable in cash at retirement or generally at age 65.

Is Robert Alpern buying or selling AbbVie (ABBV) stock in this filing?

The filing shows an acquisition through a grant, not an open-market trade. Alpern received 35 stock equivalent units as part of director fees, which track AbbVie’s stock return but are paid out in cash at a later retirement-linked date.

How many AbbVie-related stock equivalent units does Robert Alpern now hold?

After this grant, Robert Alpern holds 10,369 stock equivalent units. This total includes the newly credited 35 units plus prior balances, some of which were accumulated through a dividend reinvestment feature tied to AbbVie’s share performance.

What are stock equivalent units in the AbbVie (ABBV) director plan?

Stock equivalent units represent deferred director fees that mirror AbbVie’s stock performance. They earn the same return as if fees were invested in AbbVie shares, but they are ultimately paid in cash, generally at age 65 or upon board retirement.

When will Robert Alpern receive cash from these AbbVie stock equivalent units?

The units are scheduled to be paid in cash, generally at age 65 or when Alpern retires from the AbbVie board. Until then, the stock equivalent units continue to track AbbVie’s share performance and can grow through dividend reinvestment features.

Do these AbbVie (ABBV) stock equivalent units give Robert Alpern actual shares?

No, the award does not grant actual shares. Instead, Alpern holds stock equivalent units in grantor trust accounts that mirror AbbVie’s stock return and will be settled in cash at specified retirement-related times, not delivered as common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alpern Robert J

(Last) (First) (Middle)

1 N. WAUKEGAN ROAD

(Street)

NORTH CHICAGO ILLINOIS 60064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AbbVie Inc. [ ABBV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Equivalent Units	$217.49	03/31/2026		A		35		(1)	(1)	Common Stock	35	$217.49	10,369(2)	D

Explanation of Responses:

1. Director fees credited to stock equivalent unit accounts under grantor trusts established by the director at Abbott Laboratories and AbbVie. The stock equivalent units in the Abbott account will be paid, in cash, generally at age 65 or upon retirement from Abbott's board, and the stock equivalent units in the AbbVie account will be paid, in cash, generally at age 65 or upon retirement from AbbVie's board. The stock equivalent units in each account earn the same return as if the fees were invested in AbbVie stock.

2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

	/s/ T.O. Odutayo, Attorney-in-Fact for Robert J. Alpern	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)